Alphaeon Corporation, a wholly-owned subsidiary of Strathspey Crown Holdings, LLC, has acquired an exclusive US license for the full line of products from Teoxane Laboratories. Containing 100 percent non-animal origin, resorbable hyaluronic acid, Teoxane's dermal fillers are currently available in many markets outside the US. As part of the relationship, Alpheon will market the full line of Teoxane hyaluronic acid-based dermal fillers and cosmeceutical products to credentialed physician specialists (CPSs). In addition to the partnership agreement, Teoxane Founder and Chairwoman Valerie Taupin will join the Alphaeon Board of Directors. "The partnership with Teoxane Laboratories is a great fit for Alphaeon, as both companies possess an unparalleled commitment to delivering science-based, high-quality medical aesthetic products," said Robert E. Grant, CEO of Alphaeon, in a statement.